RJ
Rupali Jain
About Rupali Jain
Data last updated:
Rupali Jain is a Director at Novotropics Healthcare Limited (since 2024), Director at Vanbio Lifesciences Limited (since 2024) and Director at Jamkas Pharmaceuticals Private Limited (since 2021). The companies operate in Pharma.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Novotropics Healthcare Limited U47721HR2024PLC119236 | Director | 24 Feb 2024 | 2024 | Active | |
| Vanbio Lifesciences Limited U47721HR2024PLC119151 | Director | 21 Feb 2024 | 2024 | Active | |
| Jamkas Pharmaceuticals Private Limited U24239HR2021PTC096279 | Director | 13 Jul 2021 | 2021 | Active |
Board colleagues of Rupali Jain
| Name | DIN | Company | Designation |
|---|---|---|---|
| Puneet Singla | 02402163 | Novotropics Healthcare Limited , Vanbio Lifesciences Limited | Director |
| Vaneet Jain | 01841135 | Novotropics Healthcare Limited , Vanbio Lifesciences Limited and 1 more | Director |
| Gurjinder Singh | 11782773 | Jamkas Pharmaceuticals Private Limited | Director |
| Kanav Goyal | 11439059 | Jamkas Pharmaceuticals Private Limited | Additional Director |
| Manish Goyal | 10886689 | Jamkas Pharmaceuticals Private Limited | Director |
| Rakesh Kumar | 10550419 | Jamkas Pharmaceuticals Private Limited | Director |
| Sayam Mittal | 10455545 | Jamkas Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rupali Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rupali Jain
Rupali Jain currently holds 3 directorships: Novotropics Healthcare Limited (Director, since 24 Feb 2024); Vanbio Lifesciences Limited (Director, since 21 Feb 2024); Jamkas Pharmaceuticals Private Limited (Director, since 13 Jul 2021).
Rupali Jain was first appointed on 13 Jul 2021 as Director at Jamkas Pharmaceuticals Private Limited. The most recent appointment on record is 24 Feb 2024 at Novotropics Healthcare Limited.
The current boards of Rupali Jain's companies include Puneet Singla (Novotropics Healthcare Limited), Vaneet Jain (Novotropics Healthcare Limited), Gurjinder Singh (Jamkas Pharmaceuticals Private Limited), Kanav Goyal (Jamkas Pharmaceuticals Private Limited), Manish Goyal (Jamkas Pharmaceuticals Private Limited), Rakesh Kumar (Jamkas Pharmaceuticals Private Limited), among others.